Life Sciences
The research in the Life Sciences category spans a wide range of sectors related to, and driven by, the biological sciences. This range runs from basic laboratory research tools and services through applications in medicine, agriculture, and even some aspects of environmental and materials sectors. Our market research reports cover the Biotechnology, Pharmaceuticals, Diagnostics, Healthcare, and Medical Devices industries, offering in-depth analysis of markets, trends, and competitors.
By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
Page 2/28
Biotechnology in the United States
August 2013 · MarketLine
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Generics in Belgium
August 2013 · MarketLine
Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Generics in the United States
August 2013 · MarketLine
Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2007-11, and forecast to 2016). € 259,00
OTC Pharmaceuticals in the United States
August 2013 · MarketLine
OTC Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Saudi Arabia
August 2013 · MarketLine
OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in United Arab Emirates
August 2013 · MarketLine
OTC Pharmaceuticals in United Arab Emirates industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in the United Kingdom
August 2013 · MarketLine
OTC Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Brazil
August 2013 · MarketLine
OTC Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in China
August 2013 · MarketLine
OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Europe
August 2013 · MarketLine
OTC Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in the Netherlands
August 2013 · MarketLine
OTC Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Mexico
August 2013 · MarketLine
OTC Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Biotechnology in the Netherlands
August 2013 · MarketLine
Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00
Generics in France
August 2013 · MarketLine
Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in India
August 2013 · MarketLine
OTC Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Norway
August 2013 · MarketLine
OTC Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Sweden
August 2013 · MarketLine
OTC Pharmaceuticals in Sweden industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
OTC Pharmaceuticals in Taiwan
August 2013 · MarketLine
OTC Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00
Health Care Equipment & Supplies: Global Industry Guide
August 2013 · MarketLine
Global Health Care Equipment & Supplies industry guide provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 749,00
Apotex, Inc. - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
Apotex, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
AAIPharma Services Corporation - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
AAIPharma Services Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Abbott Laboratories - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
Abbott Laboratories - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Sanofi - SWOT, Strategy and Corporate Finance Report
July 2013 · MarketLine
Sanofi - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
PAREXEL International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Wyeth (formerly American Home Products Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Tesco PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Syneron Medical, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
QIAGEN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Boehringer Ingelheim GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Quest Diagnostics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Akorn, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Bayer AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioMarin Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
VHA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
MEDNAX, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Alere, Inc. (Formerly Inverness Medical Innovations, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Pharmaceutical Product Development, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Beckman Coulter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Varian Medical Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Medline Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Eurofins Scientific S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Patterson Companies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Accuray Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Millipore Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
The Ensign Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options